Descargar

Centre National de Référence pour les Infections Virales Emergentes (National Reference Center for Emerging Viral Infections)

[Declarado de conformidad con el Formulario A Parte 2 (iii)]

2. Organización o empresa pública o privada responsable
Virology Laboratory, University Hospitals of Geneva
3. Ubicación y dirección postal
Centre National de Référence pour les Infections Virales Emergentes, Laboratoire de Virologie, Hôpitaux Universitaires de Genève, Rue Gabrielle Perret-Gentil 4, CH-1205 Genève, Switzerland
4. Fuente(s) de financiación de la actividad, con indicación de si está total o parcialmente financiada por el Ministerio de Defensa

Swiss Confederation (Federal Department of Home Affairs)

5. Número de unidades de contención máxima5 que hay en el laboratorio y/o centro de investigación, con indicación de su tamaño respectivo (m2)
BL 4 , 36.00 m2
Of note, the BSL4 unit is operational and holds a license for diagnostic purposes only, as follows: “Detection of viruses in clinical samples by molecular and/or serological methods”.
BL 3 , 39.00 m2
BL 2 , 29.00 m2
6. Alcance y descripción general de las actividades, con indicación del tipo o los tipos de microorganismos y/o toxinas según proceda

The National Reference Center for Emerging Viral Diseases (CRIVE/NAVI) is a national reference laboratory by order of the Federal Office of Public Health. Its task is the detection of emerging and re-emerging viruses of all biosafety levels, especially hemorrhagic fever viruses and smallpox virus. The BSL4 unit is approved for diagnostic purposes only, which does not allow any culturing or enrichment of such viruses. The National Reference Center for Emerging Viral Diseases is part of the Laboratory of Virology (LV) at the University Hospitals of Geneva. Since January 1st, 2018, the CRIVE acts also as WHO National Center for Measles and Rubella.

Since the beginning of 2020, the CRIVE has been performing about 200’000 SARS-CoV-2 screening PCR and many thousands serologies. Currently, the CRIVE also performs Sanger and NGS sequencing on SARS-CoV-2 genomes for identification of “UK and South Africa” mutants.

The LV performs the analysis of many viruses impacting the human health as done in most of the hospitals (HIV, Hepatitis, CMV, EBV, respiratory and enteric viruses, etc.). LV does most of the viral analysis needed by an university hospital.

LV also hosts the Swiss National Center for Influenza.

For further information please visit (website in French):
https://www.hug-ge.ch/laboratoire-virologie

(4) Respecto de las instalaciones que contengan unidades de contención máxima y participen en el programa nacional de investigación y desarrollo para la defensa biológica, indíquese el nombre de la instalación y anótese: "Declarada con arreglo al formulario A, parte 2 (iii)".

(5) Con arreglo a la versión más reciente del Manual de Bioseguridad en el Laboratorio de la OMS, o a otra norma equivalente.